Editorial
doi: 10.1056/NEJMe058309.
Hepatitis B--preventable and now treatable
- PMID: 16525145
- DOI: 10.1056/NEJMe058309
Item in Clipboard
Editorial
Hepatitis B--preventable and now treatable
N Engl J Med.
.
No abstract available
Comment on
-
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.N Engl J Med. 2006 Mar 9;354(10):1001-10. doi: 10.1056/NEJMoa051285. N Engl J Med. 2006. PMID: 16525137 Clinical Trial.
-
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.N Engl J Med. 2006 Mar 9;354(10):1011-20. doi: 10.1056/NEJMoa051287. N Engl J Med. 2006. PMID: 16525138 Clinical Trial.
Similar articles
-
[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].Zhonghua Gan Zang Bing Za Zhi. 2010 Feb;18(2):109-12. doi: 10.3760/cma.j.issn.1007-3418.2010.02.008. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20196949 Clinical Trial. Chinese.
-
Changing landscape of antiviral resistance management in chronic hepatitis B.J Gastroenterol Hepatol. 2008 Sep;23(9):1314-7. doi: 10.1111/j.1440-1746.2008.05551.x. J Gastroenterol Hepatol. 2008. PMID: 18853991 No abstract available.
-
[Comparison of the therapeutical effects of entecavir and lamvudine in treatment of HBeAg-positive chronic hepatitis B].Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):873-4. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19958652 Clinical Trial. Chinese. No abstract available.
-
Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.Expert Rev Anti Infect Ther. 2008 Oct;6(5):569-79. doi: 10.1586/14787210.6.5.569. Expert Rev Anti Infect Ther. 2008. PMID: 18847396 Review.
-
Hepatitis B: the pathway to recovery through treatment.Gastroenterol Clin North Am. 2006 Dec;35(4):895-931. doi: 10.1016/j.gtc.2006.10.002. Gastroenterol Clin North Am. 2006. PMID: 17129820 Review. No abstract available.
Cited by
-
Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.Infect Dis Ther. 2016 Mar;5(1):53-64. doi: 10.1007/s40121-015-0101-y. Epub 2016 Jan 13. Infect Dis Ther. 2016. PMID: 26757720 Free PMC article.
-
Recent advances in micro/nanotechnologies for global control of hepatitis B infection.Biotechnol Adv. 2015 Jan-Feb;33(1):178-190. doi: 10.1016/j.biotechadv.2014.11.003. Epub 2014 Nov 20. Biotechnol Adv. 2015. PMID: 25450190 Free PMC article. Review.
-
Improving health Professional's knowledge of hepatitis B using cartoon based learning tools: a retrospective analysis of pre and post tests.BMC Med Educ. 2014 Nov 21;14:244. doi: 10.1186/s12909-014-0244-7. BMC Med Educ. 2014. PMID: 25412798 Free PMC article.
-
New perspective on the natural course of chronic HBV infection.Front Med. 2014 Jun;8(2):129-34. doi: 10.1007/s11684-014-0339-x. Epub 2014 May 29. Front Med. 2014. PMID: 24871442 Review.
-
Sero-epidemiology of Hepatitis B Surface Antigenaemia among Adult Nigerians with Clinical Features of Liver Diseases Attending a Primary-Care Clinic in a Resource-Constrained Setting of Eastern Nigeria.N Am J Med Sci. 2013 Apr;5(4):293-300. doi: 10.4103/1947-2714.110441. N Am J Med Sci. 2013. PMID: 23724405 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
